Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Project:Cancer

Categories:Clinical outcomes Model

6 Publications found

Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.

b

JCO precision oncology

February 1, 2023

p Cancer

c Clinical outcomes Economics Highlighted Model
Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario.

b

BMC cancer

June 10, 2021

p Cancer

c Clinical outcomes Economics Model
Cost-effectiveness analysis of first-line pembrolizumab treatment for PD-L1 positive, non-small cell lung cancer in China.

b

Journal of medical economics

April 1, 2019

p Cancer

c Change patient management Clinical outcomes Model
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.

b

Lung cancer (Amsterdam, Netherlands)

May 1, 2015

p Cancer

c Clinical outcomes Economics Model
A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis.

b

Lung cancer (Amsterdam, Netherlands)

December 1, 2013

p Cancer

c Clinical outcomes Economics Model
The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers.

b

British journal of cancer

March 13, 2012

p Cancer

c Clinical outcomes Economics Model